Effectiveness of homoeopathic medicines in tobacco use disorder

EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC MEDICINES IN REDUCING THE DEPENDENCE IN TOBACCO USE DISORDER

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031030

Enrollment

Registered

2021-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

Intervention1: HOMOEOPATHY: Individualized homoeopathic medicines prescribed according to homoeopathic principles . ROUTE OF ADMINISTRATION-ORAL potency- from 30th potency DOSE-AS PER REQUIREMENT FREQ

Eligibility

Inclusion criteria

Inclusion criteria: • Cases fulfilling the diagnostic criteria of DSM-5for tobacco dependence • Cases in the age group of 18 to 60 years

Exclusion criteria

Exclusion criteria: • Cases with life threatening conditions • Cases with co morbid major psychiatric conditions • Other substance dependence

Design outcomes

Primary

Measure	Time frame
To find out the efficacy of Individualised Homoeopathic medicines in reduction of dependence for tobacco smoking in tobacco use disorderTimepoint: 12 months	—

Secondary

Measure	Time frame
1. To arrive at a group of medicines effective in reducing the dependence in tobacco use 2. To study the changes in quality of life in patients with dependence for tobacco smoking 3. To analyse the withdrawal symptoms in patients with tobacco dependence 4. To analyse the risk factors associated with tobacco dependence Timepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Dhanaraj Kumar Rana

NHRIMH Kottayam

deepakkp57@gmail.com8129363760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026